Опубликована: Янв. 1, 2023

The global viral pandemic of COVID-19, caused by SARS-CoV-2 created an unprecedented demand for rapid diagnosis, containment, and treatment the disease. However, diverse clinical presentation COVID-19 ranging from asymptomatic cases to ARDS death in critically severe patients have complicated overall scenario. Multi-omics approaches played a vital role understanding disease pathogenesis tackling this health emergency. Omics tools unravelled mutant variants SARS-CoV-2, highlighted host-viral interaction identified probable host biomarkers that can be explored diagnosis designing novel anti-COVID-19 drugs. Several different omics techniques been documented chapter. Besides, therapeutic strategies various vaccines developed mass immunization against also mentioned. Finally, future research directions better control, management discussed.

Язык: Английский